Skip to content






































Test Approved to Determine if Breast Tumor may be Sensitive to Herceptin

The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a commonly used breast cancer treatment. The test, called Inform…
Original Article - Link to more about Test Approved to Determine if Breast Tumor may be Sensitive to Herceptin



















More Health Studies Needed on Lesbian, Gay, Bisexual and Transgendered Populations

According to a new report from the Institute of Medicine, researchers need to engage more lesbian, gay, bisexual and transgendered people in health studies.   The scarcity of research (among this population) yields an incomplete picture of LGBT health status and needs,…
Original Article - Link to more about More Health Studies Needed on Lesbian, Gay, Bisexual and Transgendered Populations